TechTalks exist to help the park's R&D community connect and start collaborations. Organized by Luris, Leiden Bio Science Park, Boerhaave Nascholing and Centrum Bioscience en Diagnostiek.

Program

• Ex vivo 3D tumor cultures for prediction of treatment response 
  Dr. Willemijn Vader (founder & CEO, Vitroscan)
• Capturing clinically relevant amounts of circulating tumor cells 
  Ir. Peter Wiegman (Co-founder & Managing Director, Idris Oncology)
• Wouldn't be that lovely: towards pretreatment knowledge of sensitivity to chemo 
  Dr. Cor de Kroon (Gynecologic Oncology, LUMC)
• Other speakers still need to be confirmed.

Followed by drinks